Conclusion
loss of skeletal muscle mass, sarcopenia
SARCOPENIA, LOSS OF SKELETAL MUSCLE MASS
Dapagliflozin treatment of individuals with type 1 diabetes, particularly non‐obese individuals and older men, might result in loss of skeletal muscle mass. However, good glycemic control during treatment might prevent the onset and progression of sarcopenia.Individuals (